{"id":"NCT00461032","sponsor":"Organon and Co","briefTitle":"Montelukast Back to School Asthma Study (0476-340)","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-Controlled Parallel Group 8-week Study to Evaluate the Efficacy and Safety of Chewable Montelukast When Initiated at the Start of the School Year in Pediatric Patients With Chronic Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2006-11","completion":"2006-11","firstPosted":"2007-04-17","resultsPosted":"2010-02-04","lastUpdate":"2022-02-02"},"enrollment":1162,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"montelukast","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This study, in children with chronic asthma, evaluates the number of days of worsening asthma during 8 weeks of treatment with montelukast after treatment is started for the first day of school.","primaryOutcome":{"measure":"Mean Percentage of Days With Worsening Asthma (as Measured on Daily Diaries) in Pediatric Asthmatic Participants","timeFrame":"8 Week treatment period initiated at the beginning of a school year","effectByArm":[{"arm":"Placebo","deltaMin":27.23,"sd":null},{"arm":"Montelukast 5 mg","deltaMin":24.26,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20674830"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":566},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Asthma","Sinusitis","Pharyngolaryngeal pain"]}}